Does PMDD Go Away After Menopause? What Actually Changes
Updated: Aug 27
Last reviewed: 08/22/2026
Reviewed by: Dr. Kiesa Kelly
If you have lived with premenstrual dysphoric disorder for years, the question eventually arrives on its own: does this end when my cycles do?
The short answer is a qualified yes. PMDD is tied to the ovarian hormone cycle, and when ovulation stops, the driver stops. But "eventually yes" is not the same as "soon," and it is not the same as "completely." The years before your last period are often the hardest part of the whole condition, certain hormone therapies can bring cyclical symptoms back afterward, and any depression or anxiety sitting alongside PMDD will not leave when your cycles do.
This article is about the whole arc, not just the endpoint.
In this article, you'll learn:
Why PMDD is expected to resolve after menopause, and what that is based on
Why perimenopause frequently makes symptoms worse before they get better
Three situations that change the answer for an individual person
How clinicians tell a resolving premenstrual disorder from a mood disorder that was always there
What to do in the meantime, and what not to do
What it is - the one-paragraph answer
Premenstrual dysphoric disorder is a cyclical condition in which significant mood and physical symptoms appear in the luteal phase — the roughly two weeks after ovulation — and remit shortly after menstruation begins. Because the diagnosis is defined by that timing, the cessation of ovulation removes the mechanism that produces the pattern. Most women with PMDD can expect cyclical symptoms to resolve after menopause. What complicates the picture is everything between here and there: the perimenopausal transition, which is characterized by erratic rather than absent hormone activity; hormone therapy, which can reintroduce a cyclical pattern; and co-occurring conditions, which have their own course entirely. If you are still sorting out whether what you have is PMDD in the first place, our guide to PMDD versus perimenopause covers that differential.
Key takeaway: 🔄 PMDD resolves because ovulation stops, not because you reach a particular age. Anything that keeps a hormonal cycle running keeps the mechanism available.
Signs and symptoms
Core features
The defining feature of PMDD is not symptom severity but symptom timing. Diagnostic criteria require that symptoms appear in the final week before menses, improve within a few days of onset, and become minimal or absent in the week after — and that this pattern is confirmed by prospective daily ratings across at least two consecutive symptomatic cycles rather than recalled from memory [1]. Retrospective reports are unreliable in both directions, which is why the charting requirement exists.
This matters enormously for the menopause question, because timing is exactly what the transition disrupts. Our post on PMDD as something other than bad PMS covers the baseline picture in more detail.
How it shows up day to day
You have known for years that the second half of your cycle belongs to something else. You schedule around it. The irritability arrives on a predictable day, the sense of dread follows, and by the time your period starts you can feel the weather change. You have built a life that accommodates a two-week visitor, and the accommodation works because the visitor keeps a schedule.
Then, somewhere in your forties, the schedule breaks. Some months the bad stretch lasts four days, others it lasts sixteen. A cycle arrives at twenty-three days, then thirty-nine. You cannot plan around it anymore, and the coping strategies that depended on knowing when it was coming stop working. Many women read this as PMDD getting dramatically worse. What is often happening is that erratic hormonal fluctuation has replaced a predictable one, and the same underlying sensitivity is now being triggered unpredictably.
Sleep is frequently where this lands first. Both the luteal phase and the menopause transition disrupt sleep in their own right, and the combination can produce a level of exhaustion that makes every other symptom harder to tolerate. If chronic insomnia has become its own problem, it is worth treating as one rather than waiting for it to resolve on its own.
Key takeaway: 🌗 In perimenopause, symptoms often become less predictable rather than simply more severe. That is a different problem, and it responds to different strategies.
How it is assessed
Three misconceptions come up repeatedly in this conversation, and each leads somewhere unhelpful.
"Menopause will fix this, so there is no point treating it now." The perimenopausal years can last a decade, and they are frequently the most symptomatic stretch of the entire condition. Declining to treat a decade of significant symptoms because they will eventually end is not a neutral choice.
"If my periods stopped, PMDD should be over." Only if ovulation stopped. Menstruation and ovulation are not the same event, and a hysterectomy that leaves the ovaries in place removes the bleeding while the hormonal cycle continues underneath. Symptoms can persist on the old rhythm with nothing visible to mark it.
"My mood problems continued, so I never really had PMDD." A separate depressive or anxiety disorder can coexist with a genuine premenstrual disorder. Both can be true. Persistence after menopause tells you something else also needs attention — not that the original pattern was imaginary.
What an evaluation looks at
A careful assessment starts with prospective symptom charting, because that is what separates a premenstrual disorder from a continuous condition that worsens premenstrually. Validated scoring approaches for this exist and are more accurate than clinical impression alone [2].
It also screens for what else is present. Depression and anxiety screeners are a starting point for identifying conditions that will need their own treatment regardless of what happens to your cycles, and a broader mental health screening can map the fuller picture. Where the presentation is complex or long-standing, a full psychological evaluation can clarify what is cyclical, what is constant, and what is being driven by something else entirely.
What rules it in or out
The distinguishing question is whether there is a genuine symptom-free window. In PMDD, the follicular phase is meaningfully clear. In premenstrual exacerbation of an underlying mood disorder, symptoms are present throughout and simply intensify before menses. That difference is difficult to see from memory and straightforward to see on a chart — and it is the single best predictor of what will happen when cycles stop.
Key takeaway: 📋 The clear window is the thing to look for. A genuinely symptom-free follicular phase predicts resolution after menopause; no clear window predicts that something will remain.
Why it happens
The mechanism explains both halves of the answer, which is why it is worth understanding.
Women with PMDD do not have abnormal hormone levels. Repeated study has found their estradiol and progesterone to be indistinguishable from women without the condition. What differs is sensitivity — a differential response to normal hormonal events, particularly involving progesterone-derived neurosteroids and the brain's inhibitory signaling.
The more precise finding is about change. In experimental work using medication to suppress ovarian function and then add hormones back, PMDD symptoms were triggered by the change in ovarian steroid levels rather than by continuous stable levels of those same hormones [3]. Symptoms did not appear when levels were held steady, even when they were held steady at a high level. The trigger was the transition itself.
That framework fits the clinical picture across the menopausal arc, though it is worth being clear that the experimental work was done in a controlled setting rather than by following women through menopause. Perimenopause is characterized by large, erratic hormonal swings — more change, less predictably — which is consistent with symptoms worsening. Postmenopause is characterized by stable low levels — very little change — which is consistent with symptoms resolving. And cyclical hormone therapy deliberately reintroduces a monthly hormonal shift, which is consistent with the observation that women with a premenstrual disorder history can develop recurrent cyclical symptoms on those regimens [4].
Key takeaway: 🧪 The evidence points to hormonal change as the trigger rather than hormone levels. That single idea explains why perimenopause is worse, why postmenopause is better, and why some hormone regimens bring symptoms back.
What actually helps
Evidence-based options
Keep charting, especially now. When cycles become irregular, tracking is the only way to know whether symptoms are still cycle-linked. This is also the information that tells your clinician whether a change in treatment makes sense.
Treat what is in front of you. Established treatments for premenstrual disorders — including SSRIs, which can be dosed continuously or only in the luteal phase, and hormonal approaches that suppress ovulation — remain appropriate during the transition [5]. Our overview of PMDD treatment options covers the range in more depth.
Treat the co-occurring conditions separately. If depression, anxiety, or a sleep disorder is present, it needs its own plan. Those conditions will not resolve with your cycles, and treating them often improves your tolerance for the cyclical symptoms in the meantime. Ongoing therapy can address the pieces that hormones do not.
Raise the hormone-therapy question before you start. If you are considering HRT for menopausal symptoms and you have a PMDD history, that history is directly relevant to which regimen is chosen. Say so up front.
What to be cautious of
Do not stop or change any prescribed medication on your own. This is the most important sentence in this article. Discontinuing treatment in anticipation of menopause can leave you unmedicated through the most symptomatic years of the entire condition. Any change belongs in a planned conversation with your prescriber.
Be cautious of treating the whole midlife picture as one thing. Attention difficulties, cyclical mood symptoms, and sleep disruption can each have separate drivers in these years, and collapsing them into a single explanation tends to leave at least one of them untreated. Our post on PMDD, perimenopause, and ADHD pattern shifts walks through how those pieces come apart.
Be cautious of waiting. Menopause is not a treatment plan, and the average woman is in the transition for years.
Key takeaway: ⏳ Perimenopause is not a waiting room. It is the part of the condition that most often needs active treatment.
When to get evaluated
A framework you can apply to your own situation:
If your cycles have stopped for twelve months and your symptoms have settled — the pattern resolved as expected. Nothing further is needed for the PMDD itself.
If your cycles are irregular and symptoms have become unpredictable — this is the transition, and it is the point at which treatment usually needs revisiting rather than stopping. Bring your charting to that conversation.
If your cycles have stopped but the mood symptoms have not — something other than PMDD is present and needs its own assessment. That is a common and treatable outcome, not a failed diagnosis.
If cyclical symptoms returned after you started hormone therapy — tell the prescriber managing your HRT. The regimen itself may be the relevant variable.
If your periods stopped surgically but your symptoms did not — check whether your ovaries were removed. If they were not, the hormonal cycle is likely still running.
Key takeaway: 🗓️ What your symptoms do after your cycles stop is diagnostic information in its own right. Resolution confirms the picture; persistence identifies something that was always separate.
Next step - getting support
PMDD does generally end when cycles do. That is a real and reasonable thing to hold onto, and it is genuinely good news after years of a condition that can feel unending.
It is also not a plan for the years in between, and it is not a promise that everything difficult will resolve at once. The honest version is narrower and more useful: the cyclical part is expected to lift, the timing depends on when ovulation actually stops rather than on your age, certain hormone regimens can restart the pattern, and anything running underneath the cycle will still be there afterward and deserves its own treatment. Knowing which of those applies to you is a question worth answering now, with charting and a clinician, rather than waiting several years to find out by experiment.
Navigating a women's-health or hormonal change?
Hannah Pollok works at the intersection of physical and mental health — hormones, reproductive changes, and the mood and cognitive shifts that come with them.
Frequently Asked Questions
Can hormone therapy after menopause bring PMDD symptoms back?
It can, and the pattern is specific to how the progestogen is given. Regimens that deliver progestogen cyclically reproduce the hormonal shift that drives premenstrual symptoms, and women with a PMDD history have been observed to develop recurrent cyclical symptoms on those regimens. Continuous rather than cyclical delivery is one of the options a prescriber may consider. This is a conversation to have with the clinician managing your hormone therapy.
Does a hysterectomy stop PMDD if the ovaries are left in place?
Usually not. PMDD is driven by the ovarian hormone cycle, not by menstruation itself, so removing the uterus stops periods while ovulation continues. Symptoms can persist on the same rhythm without the bleeding that used to mark it, which makes the pattern harder to recognize and track. Cycle timing can still be established through symptom charting or hormonal testing.
How long after my last period should premenstrual symptoms settle?
Menopause is confirmed after twelve consecutive months without a period, and cyclical symptoms generally ease as ovulation becomes infrequent and then stops. The perimenopausal years leading up to that point are often the hardest, because hormone levels fluctuate unpredictably rather than following a predictable cycle. There is no fixed timeline, and a clinician tracking your symptoms alongside your cycle history can give you a far better estimate than an average can.
If my mood symptoms continue after menopause, was it ever PMDD?
Possibly, and the two situations can coexist. PMDD requires symptoms tied to the luteal phase that remit after menstruation, confirmed by prospective daily ratings across at least two cycles. A separate depressive or anxiety disorder can run alongside a genuine premenstrual disorder and will not resolve when cycles stop. Continuing symptoms usually mean something else needs treatment in its own right, not that the original diagnosis was wrong.
Should I stay on my PMDD treatment while waiting for menopause?
Do not stop or change any prescribed medication without talking to the clinician who prescribed it. Stopping treatment in anticipation of menopause can leave you unmedicated through the perimenopausal years, which are frequently the most symptomatic part of the transition. Any taper or change should be planned deliberately with your prescriber, based on your symptom tracking rather than your age.
About the Author
Dr. Kiesa Kelly is a licensed clinical psychologist and the founder of ScienceWorks Behavioral Healthcare. Her background includes more than 20 years of experience in psychological assessment and evidence-based treatment, with clinical training at the University of Chicago, Vanderbilt University, and the University of Wisconsin.
Her clinical interests include mood conditions in women across the reproductive lifespan, where cyclical and non-cyclical presentations are frequently confused, and the differential assessment work required to tell them apart. She reviews every clinical article published on this site for accuracy.
References
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022. https://www.psychiatry.org/psychiatrists/practice/dsm
2. Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, et al. Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina Premenstrual Assessment Scoring System (C-PASS). American Journal of Psychiatry. 2017;174(1):51-59. https://psychiatryonline.org/doi/10.1176/appi.ajp.2016.15121510
3. Schmidt PJ, Martinez PE, Nieman LK, et al. Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels. American Journal of Psychiatry. 2017;174(10):980-989. https://psychiatryonline.org/doi/10.1176/appi.ajp.2017.16101113
4. Premenstrual syndrome (PMS): a peri-menopausal perspective. Maturitas. https://www.sciencedirect.com/science/article/abs/pii/S0378512212001119
5. American College of Obstetricians and Gynecologists. Management of premenstrual disorders: ACOG Clinical Practice Guideline No. 7. Obstetrics & Gynecology. 2023;142(6):1516-1533. https://www.acog.org/clinical/clinical-guidance/clinical-practice-guideline/articles/2023/12/management-of-premenstrual-disorders
6. Management of premenstrual disorders: ACOG Clinical Practice Guideline No. 7. PubMed record. 2023. https://pubmed.ncbi.nlm.nih.gov/37973069/
7. Differential effects of ovarian steroids in women with and without premenstrual dysphoric disorder: a replication and extension of findings. American Journal of Psychiatry. https://psychiatryonline.org/doi/abs/10.1176/appi.ajp.20240596
8. Diagnostic validity of premenstrual dysphoric disorder: revisited. Frontiers in Global Women's Health. 2023. https://www.frontiersin.org/journals/global-womens-health/articles/10.3389/fgwh.2023.1181583/full
9. Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression. Frontiers in Pharmacology. 2025. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1528544/full
10. Recent advances in understanding and management of premenstrual dysphoric disorder and premenstrual syndrome. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066446/
11. Premenstrual Dysphoric Disorder. StatPearls, NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK532307/
Disclaimer
This article is for informational and educational purposes only and does not constitute medical or psychological advice, diagnosis, or treatment. It is not a substitute for care from a qualified clinician, and it should never be used as a basis for starting, stopping, or changing any medication. Decisions about hormone therapy, antidepressants, or any other treatment belong with the prescriber who knows your history. If you are in crisis, contact the 988 Suicide and Crisis Lifeline or your local emergency services.